Company Filing History:
Years Active: 2022
Title: Thomas Svab: Innovator in Immunogenic Compositions
Introduction
Thomas Svab is a notable inventor based in Plains, PA (US). He has made significant contributions to the field of immunology through his innovative work on polysaccharide-protein conjugates. His research focuses on enhancing the efficacy of immunogenic compositions, which are crucial for vaccine development.
Latest Patents
Thomas Svab holds a patent for "Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier." This invention provides immunogenic compositions that include one or more polysaccharide-protein conjugates. These conjugates involve polysaccharides obtained from bacterial capsules that are linked to diphtheria toxin fragment B (DTFB) or its variants. The compositions may also include multivalent pneumococcal polysaccharide conjugate compositions, enhancing their potential effectiveness in immunization.
Career Highlights
Throughout his career, Thomas has been associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work has contributed to advancements in vaccine technology and immunology, showcasing his commitment to public health and safety.
Collaborations
Thomas has collaborated with esteemed colleagues, including John E. MacNair and Michael Albert Winters. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of immunology.
Conclusion
Thomas Svab's contributions to the development of immunogenic compositions highlight his role as an influential inventor in the pharmaceutical industry. His work continues to impact vaccine development and public health initiatives.